Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241713345 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Nobunao Wakabayashi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA. Hauptthemen laut MEDLINE: Fatty Liver, NF-E2-Related Factor 2, Lipodystrophy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Washington State Andy Hill CARE Fund, National Institutes of Health, National Cancer Institute.
Abstract (Originalsprache)
Lipodystrophy is a disorder featuring loss of normal adipose tissue depots due to impaired production of normal adipocytes. It leads to a gain of fat deposition in ectopic tissues such as liver and skeletal muscle that results in steatosis, dyslipidemia, and insulin resistance. Previously, we established a Rosa NIC/NIC::AdiCre lipodystrophy model mouse. The lipodystrophic phenotype that included hepatomegaly accompanied with hepatic damage due to higher lipid accumulation was attenuated substantially by amplified systemic NRF2 signaling in mice with hypomorphic expression of Keap1; whole-body Nrf2 deletion abrogated this protection. To determine whether hepatic-specific NRF2 signaling would be sufficient for protection against hepatomegaly and fatty liver development, direct, powerful, transient expression of Nrf2 or its target gene Nqo1 was achieved by administration through hydrodynamic tail vein injection of pCAG expression vectors of dominant-active Nrf2 and Nqo1 in Rosa NIC/NIC::AdiCre mice fed a 9% fat diet. Both vectors enabled protection from hepatic damage, with the pCAG-Nqo1 vector being the more effective as seen with a ~50% decrease in hepatic triglyceride levels. Therefore, activating NRF2 signaling or direct elevation of NQO1 in the liver provides new possibilities to partially reduce steatosis that accompanies lipodystrophy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Research Program, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
- Division of Endocrinology, Columbia University, New York, NY 10032, USA.
ORCID-Profile: Tanvi Joshi, Thomas W Kensler
Förderung
- NCI NIH HHS
- Washington State Andy Hill CARE Fund
- National Institutes of Health, National Cancer Institute
Zitieren
APA
Wakabayashi, N., Yagishita, Y., Joshi, T., & Kensler, T. W. (2023). Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241713345
Vancouver
Wakabayashi N, Yagishita Y, Joshi T, Kensler TW. Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241713345
BibTeX
@article{Wakabayashi2023,
author = {Wakabayashi, Nobunao and Yagishita, Yoko and Joshi, Tanvi and Kensler, Thomas W},
title = {Forced Hepatic Expression of NRF2 or NQO1 Impedes Hepatocyte Lipid Accumulation in a Lipodystrophy Mouse Model},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241713345}
}
EUVIMED